This case report from a Consumer or other non health professional in USA was received via Sanofi Aventis at EMD
Serono on 12-Jun-2015. 
A female patient of an unknown age experienced JOHN CUNNINGHAM VIRUS, WELTS AT INJECTION SITES 
after REBIF was started on an unspecified date at an unspecified dose for an unknown indication. Action taken with
Rebif therapy at the time of reporting was not reported. 
Events/Outcome: JOHN CUNNINGHAM VIRUS: Not Reported, WELTS AT INJECTION SITES: Not Reported.
The reporter assessed as john Cunningham virus as not suspected related to Rebif and welts at injection sites as 
suspected related to Rebif.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 24 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information